Sign up


Match Document Document Title
7438918 Lipid A deficient mutants of Neisseria meningitidis  
The invention provides lipid A deficient mutant Neisseria meningitidis cells, pharmaceutical compositions incorporating such cells, and methods of using such cells.
7427499 Bifidobacterium longum  
17It is intended to provide Bifidobacterium longum having the following bacteriological properties and microbial powders, foods and beverages containing this Bifidobacterium longum: (1) having such...
7427397 Probiotic propionibacterium  
The present invention relates to probiotic Propionibacterium strains and their use in the preparation of probiotic supplements and foods. The invention relates to the provision of Vitamin B12,...
7422737 Porous freeze-dried hydrocolloid beads containing viable microorganisms for biological control  
The present invention provides cellular solid carriers comprising viable microorganisms capable of controlling plant pathogens. The cellular solid carriers are formed from water-soluble...
7413728 Immune modulator  
Use of an immune modulator composition and/or pharmaceutical composition comprising a whole cell of a bacterium from the genera Rhodococcus, Gordonia, Nocardia, Dietzia, Tsukamurella and...
7407652 Probiotic system for aquaculture  
Probiotic bacterial strains are provided which inhibit or prevent growth or pathogenic bacteria in marine organisms. Also provided are methods of culturing marine organisms using the probiotic...
7396671 Biotechnological process for neutralizing alkaline beverage industrial waste water  
The present invention provides a process of neutralizing beverage industrial wastewater by a bacterial strain Exiguobacterium sp. isolated in India, which strain is capable of bring down the pH of...
7393541 Mycobacterial vaccine  
Compositions and methods for enhancing the immunity of a subject or vaccinating a subject against mycobacterial infections are disclosed. The invention provides compositions comprising formalin...
7393678 Klebsiella pneumoniae inoculants for enhancing plant growth  
A biological inoculant for enhancing the growth of plants is disclosed. The inoculant includes the bacterial strains Herbaspirillum seropedicae 2A, Pantoea agglomerans P101, Pantoea agglomerans...
7384628 Lactic acid bacteria and its use in direct-fed microbials  
A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis, and Lactobacillus brevis. The composition is suitable for...
7364740 Molecular differences between species of the M. tuberculosis complex  
Specific genetic deletion are identified in mycobacteria isolates, including variations in the M. tuberculosis genome sequence between isolates, and numerous deletion present in BCG as compared to...
7361497 Probiotic bacteria  
Strains of probiotic bacteria, their isolation, characteristics and methods of use to prevent or treat carriage by a food production animal of Salmonella that causes human salmonellosis are...
7335352 Method of identifying agents that inhibit quorum sensing activity of gamma-proteobacteria  
Screening assays that allow for the identification of agents that increase acyl homoserine lactone (AHL) acylase expression and/or AHL acylase activity in γ-proteobacteria such as Pseudomonas ...
7323328 Obligately symbiotic thermophile Symbiobacterium toebii SC-1 producing thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase  
The present invention relates to a novel obligately symbiotic thermophile Symbiobacterium toebii SC-1 (Accession NO: KCTC 0685BP), and a thermostable L-tyrosine phenol-lyase and L-tryptophan...
RE40023 Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use  
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at...
7312065 Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof  
The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are...
7267816 Ammonia-oxidizing bacteria  
Described herein are novel ammonia-oxidizing bacteria as well as isolated nucleotide sequences representative of 16S rDNA of these ammonia-oxidizing bacteria. Particular bacteria of the present...
7262151 Methods and compositions for production of lipo-chito oligosaccharides by rhizobacteria  
Lipo-chito oligosaccharides (LCOs) are produced by culturing rhizobacteria cells in or on a culture medium comprising at least one of: jasmonic acid or a derivative thereof; linoleic acid or a...
7261899 Method of producing thy A-strains of Vibrio cholerae, such strains and their use  
A method of producing a thy A−strain of vibrio cholerae comprising the step of site-directed mutagenesis in the V. cholerae chromosome at the locus of the thy A gene SEQ ID NO: 1 of FIG. 1, is d...
7250162 Lactic acid bacteria inhibiting halitosis  
The present invention relates to novel bacteria inhibiting halitosis or oral malodor. In particular, the present invention relates to novel lactic acid bacteria belonging to the genus Weissella,...
7247296 Radiation therapy by accumulation of therapeutic radionuclides in tumor-targeting bacteria  
The invention can be summarized as follows. According to the present invention there is provided an attenuated, tumour-targeting bacterium comprising a heterologous nucleotide sequence encoding a...
7244607 Chromobacterium subtsugae sp. nov. for control of insect pests  
Chromobacterium suttsuga sp. nov., a new species of the genus Chromobacterium which possesses insecticidal activity, is described. The invention also relates to insecticidally-active metabolites...
7241441 Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities  
The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune...
7241439 Biopesticide compositions  
The present invention relates to compositions suitable for use against one or more pathogens comprising at least one antagonistic micro-organism and at least one stimulating agent, which may be...
7238345 Recombinant microorganism expressing meningococcal class 1 outer membrane protein  
Outer-membrane vesicles, Class 1 outer membrane proteins of Neisseria meningitidis, fragments or oligopeptides containing epitopes of the Class I OMP can be used to immunize against meningococcal...
7235234 Bacterial delivery system  
We describe a bacterial delivery system for the delivery of DNA and antigens into cells. We constructed an attenuated bacterial vector which enters mammalian cells and ruptures delivering...
7235395 Lactic acid bacteria as agents for treating and preventing allergy  
The present invention pertains to novel strains of lactic acid bacteria capable of reducing an individual's tendency to react allergic against a variety of different allergens. In particular, the...
7229616 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis  
The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis, for the...
7226590 Antimicrobial composition  
This invention provides novel Streptococcus salivarius, compositions containing same, and use of S. salivarius strains as antimicrobial agents. The strains are bacterial inhibitors with respect to...
7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it  
Describes a new strain of Streptococcus thermophilus ssp. salivarius (deposited on 4 Dec. 2001 at the DSMZ—Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany, with a...
7204993 Streptococcus agalactiae vaccine  
A composition prepared from intact killed cells of isolated β-hemolytic Streptococcus agalactiae and a concentrated extract of a culture of β-hemolytic Streptococcus agalactiae, is effective for t...
7198785 Systems and methods related to degradation of uremic toxins  
The present invention generally relates to the treatment of uremic toxins in vivo using uremic toxin-treating enzymes, and/or cells capable of producing uremic toxin-treating enzymes or otherwise...
7195906 Bifidobacterium in the treatment of inflammatory disease  
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the...
7189557 Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli  
An improved process for the production of streptokinase using a genetically engineered strain of Escherichia coli which overproduces streptokinase intracellularly and more particularly, the overall...
7172762 Erysipelothrix rhusiopathiae antigens and vaccine compositions  
The invention relates to stabilized antigen compositions of Erysipelothrix rhusiopathiae and vaccine formulations containing such antigen compositions. Antigens of the invention are effective in...
7169383 Attaching substances to micro-organisms  
The invention relates to surface display of proteins on micro-organisms via the targeting and anchoring of heterologous proteins to the outer surface of cells such as yeast, fungi, mammalian and...
7163820 Escherichia coli strain for an oral vaccine against post-weaning diarrhea in pigs  
The invention relates to a strain suitable for producing a live, orally applicable Escherichia coli vaccine for the prevention of post-weaning diarrhoea in pigs, and the procedure suitable for...
7157258 Particles containing coated living micro-organisms, and method for producing same  
Particles containing dehydrated living micro-organisms are coated with a homogeneous layer of hydrophobic substance selected to reduce the risks of degradation of the micro-organisms by...
7144723 Marine actinomycete taxon for drug and fermentation product discovery  
The invention is the discovery of an actinomycete genus, given the name Salinospora gen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature...
7141395 Biological control of crown gall disease  
The present invention provides a method for controlling crown gall disease in plants using an effective quantity of α-proteobacteria that produces trifolitoxin (TFX). The present invention also ...
7118739 Biocontrol of plant diseases caused by Fusarium species with novel isolates of Pantoea agglomerans  
Microbiological agents are provided for control of certain diseases of wheat and other cereals caused by Fusarium species, including Fusarium head blight of wheat and other cereals. These agents...
7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts  
This invention relates to an immunogenic composition comprising a bacterial extract containing at least one expression products of the vrg genes of a strain of Bordetella chosen from B. pertussis,...
7101558 High yield pertussis vaccine production strain and method for making same  
The present invention provides a vaccine production strain of Bordetella bronchiseptica that produces a pertussis toxin in high yield. The present invention provides a method for creating a...
7097831 α-Amylase-resistant starch for producing foodstuff and medicaments  
The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear α-1,4-D-glucans. The invention also related to the utilization of resistant ...
7094410 DNA vaccine against proliferating endothelial cells and methods of use thereof  
A DNA vaccine effective for inhibiting endothelial cell proliferation comprises a DNA construct operably encoding a vascular endothelial growth factor (VEGF) receptor protein. This invention...
7090875 External skin preparations and process for producing the same  
External skin preparations containing one or more members selected from among a fermentation product, which is obtained by treating a bean extract with a microorganism, vitamin A and its...
7090839 Method of treatment of human immunodeficiency diseases  
The present invention relates to a method of treating human immunodeficiency diseases with electroactivated aqueous salt solutions followed by reconstitution of a healthy microflora.
7090838 Bacterium NRRL B-30043 for controlling algae  
A method of reducing or eliminating off-flavor in water or fish by controlling cyanobacteria or algae in the water wherein cyanobacteria or algae produce agents that cause the off-flavor. The...
7078191 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation  
The present invention relates to novel compositions useful for elucidating the onset or progress of diseases such as Huntington's disease, that are associated with the formation of fibrils or...
7067122 Modified live Edwardsiella tarda vaccine for aquatic animals  
A safe and effective live vaccine against Edwardsiella tarda in fish was created through the induction of rifampicin resistance in a native Edwardsiella tarda isolate. Single immersion exposure or...